Atlas Trials

Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors

Clinical trial NCT06742593 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06742593
Sponsor
Suzhou Maximum Bio-tech Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Brain (Nervous System) CancersBrain and Central Nervous System TumorsBrain Tumors
Start date
2025-01-01
Primary completion
2025-12-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.